Kwality Pharmaceuticals Limited
NSE: KPLMarket Closed • NSE
Day range
52 week range
Kwality Pharmaceuticals Limited closed at INR3402.90 (+2.62%) on volume 0.63x its 20-day average, trading 13.83% below its 52-week high.
2026-Q2
Q2 FY2026 Financial Results
PAT moved +4% QoQ
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Strong Capital Efficiency: ROCE stands at 23.9%
Low Debt Profile: Debt-to-Equity is comfortable at 0.40x
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Pharmaceuticals: Major.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Ownership distribution
Category trends
Hover over a period for exact holdings
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
Kwality Pharmaceuticals LimitedKPL Current stock | ₹3,656.36 | 43.57 | 0.00% | ₹162.00 | ₹26.00 | +45.95% | +116.67% |
 Fermenta Biotech LimitedFERMENTA Open analysis | ₹1,393.40 | 23.46 | 0.77% | ₹96.16 | ₹7.68 | — | — |
 Praveg LimitedPRAVEG Open analysis | ₹605.31 | — | 0.22% | ₹46.00 | -₹13.00 | +17.95% | -116.67% |
Incorporated in 1983, Kwality Pharma is in the business of manufacturing & trading in Pharmaceuticals & allied products[1]
IndiaHealth Technology
Is Kwality Pharmaceuticals Limited Shariah compliant?
Kwality Pharmaceuticals Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (3.56%) complies with AAOIFI threshold (≤ 33%).
What is Kwality Pharmaceuticals Limited's current valuation relative to peers?
Kwality Pharmaceuticals Limited trades at a P/E of 43.6x compared to the sector median of 33.5x, and a Price-to-Book of 10.6x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.40x and a Net Debt to EBITDA ratio of 1.1x. Interest coverage is 10.7x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at steady rates while net profit growth averaged 23%.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.